In Brief: Acuson/Kaiser Permanente
This article was originally published in The Gray Sheet
Executive Summary
Acuson/Kaiser Permanente: Acuson to become two-year, sole-source provider of cardiac ultrasound systems for adult, pediatric, intraoperative and stress echocardiography applications to the 323-hospital health management organization under an Oct. 28 agreement. The deal calls for the HMO to purchase replacement and additional cardiac ultrasound units such as Acuson's Sequoia C256 and Aspen systems. The pact follows an August agreement making Acuson Kaiser's sole-source provider of radiology and vascular ultrasound systems...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.